SKAN US Launches
Introducing technology enabling
higher catalytic efficiency and
featuring award-winning PSI-L
modular isolator system.
SKAN, a worldwide provider of
pharmaceutical aseptic isolation and
hydrogen peroxide-based sterilization
technologies, is launching its newly
patented SKAN NANOX Catalyst
Technology at the 2017 INTERPHEX show.
“The patented SKAN NANOX Catalysts
were developed in cooperation with
a leading Swiss University utilizing
nanoparticles,” said Larry Cabeceiras,
president, SKAN US. “This catalyst was
engineered to enable higher efficiency
breakdown of hydrogen peroxide at
lower temperatures with performance far
superior to any other catalyst available on
the market today.
“With the launch of our SKAN NANOX
catalyst technology, we continue to
innovate by reducing the overall time and
energy required for hydrogen peroxide
based decontamination and aeration, while
positively impacting the effect on the
environment,” Cabeceiras continued.
SKAN is also highlighting its award winning
modular small-scale aseptic processing
isolator, Pharmaceutical Safety Isolator
(PSI-L) with SARA Material Airlocks for
conventional aseptic applications.
The PSI-L is a modular and extendable
isolator system with a unique L-shaped
flange, which enables quick equipment
changes to host different filling machines
or other pharmaceutical processes.
The short decontamination cycle and
the return air filter (FIPA) make it a
universal, aseptic workspace for the
production of aseptic and/or highly active
The isolator and product machine
modules (such as the VarioSys custom-fit modules) fit together on the “lock-and
key” principle. The basic unit (L-flange) of
the isolator is equipped with an inflatable
seal to ensure that the machine module is
Designed as a space-saving
manufacturing solution, VarioSys, was
awarded the INTERPHEX 2016 Biotech
Innovation Award which recognizes
innovative technologies that address
an industry need, but does so in such a
way as to exceed previous standards,
thereby making the manufacturing
process simpler and more cost effective.
VarioSys features a flexible
processing line, modular design, and
standardization of subassemblies. The
PSI-L enables aseptic production in
clean room Grade A conditions with
individual production modules installed
to fit on the lock-and-key principle,
for instance, a machine for processing
syringes in nests or a filling and closing
machine for vials.
INTERPHEX Live presentation
As part of INTERPHEX’s three-day
technical conference, SKAN experts
will lead an INTERPHEX Live panel
discussion entitled, “Evolution of
Pre-filled Syringes,” taking place
today (Tuesday, March 21) from
11: 15 am-12:00 noon.
Beginning at 5:00 pm today (Tuesday),
SKAN will present at its booth an
opportunity to gain knowledge and
updates from SKAN’s Sterility Testing
Conference and Aseptic Barrier Technical
Summit that was held last October.
Techniques and lessons learned from
manufacturing companies will be shared
along with a demonstration video of the
new SKAN NANOX catalyst technology.
SKAN US, Inc., is a wholly owned subsidiary
of SKAN AG Switzerland (founded in
1968) and a provider of state-of-the-art
barrier isolation technology with over 9,000
installations in more than 43 countries.
A demonstration video on the
SKAN NANOX and the PSI-L will be
presented in the company’s Booth
No. 3140 this week.
SKAN’s modular L-flange isolator. The system includes a base isolator with a removable floor and
back wall. One isolator can be used for multiple aseptic processing steps. Applications include:
aseptic compounding, filling, freeze drying, device assembly, and bioprocessing.